Availability and Pricing of Essential Medicines in Myanmar
No hay miniatura disponible
Fecha
Autores
Título de la revista
ISSN de la revista
Título del volumen
Editor
Washington, DC: World Bank
Resumen
Descripción
This report on the Availability and
Pricing of Essential Medicines in Myanmar relies on multiple
assessments (2021 - 2023) conducted jointly by the World
Bank and World Health Organization as well as other publicly
available information. This report provides an overview of
findings from a mixed-method study to assess the impact of
the COVID-19 pandemic and political instability on Myanmar’s
healthcare system, focusing on the availability of essential
medicines. This study combines quantitative data collection
from retail pharmacies and qualitative interviews with key
stakeholders in the pharmaceutical industry of the private
sector. The study further explored the coping mechanisms
households and healthcare providers employ to address the
rising prices of essential medicines. Many individuals with
chronic conditions reported reducing or skipping medication
intake due to financial constraints. Healthcare providers
adjusted their prescription choices, often opting for more
affordable brands, to mitigate the impact on patients.
However, these coping mechanisms were insufficient to
alleviate the negative consequences of rising medicine
prices. Based on the findings, this study emphasizes the
urgent need to address the root causes of rising medicine
prices in order to ensure the availability and affordability
of essential medicines for all individuals in Myanmar. By
gaining a comprehensive understanding of the prevailing
issues, targeted interventions and programs can be designed
to safeguard the health and wellbeing of Myanmar’s population.
Palabras clave
DISEASE CONTROL, HEALTH SERVICE DELIVERY, SOCIAL PROTECTION, COVID-19, GOOD HEALTH AND WELL-BEING, SDG 3